NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched the HemeScreen® Anemia Panel as part of its suite of ...
A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on dialysis. A Food and Drug Administration advisory panel voted 15-1 on Wednesday, with one ...
The Food and Drug Administration said Friday that it will form a panel to address safety concerns surrounding anemia drugs made by Amgen Inc. and Johnson & Johnson. The panel is set to meet September ...
A new drug from Affymax Inc to be used to treat anemia in patients with chronic kidney disease who are on dialysis has won the FDA panel approval. A Food and Drug Administration advisory panel voted ...
Kidney patients who aren't on dialysis should still get their anemia-drug treatments, an FDA advisory panel says. After discussing new safety data on Amgen's high-tech anemia treatment Aranesp, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results